Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07048067 · ClinicalTrials.gov registry record
Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 500
- Enrollment target
NCT07048067: Completed study, sponsored by The Methodist Hospital Research Institute.
NCT07048067 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07048067 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior to January 2023 and after January 2023. This study is one of a kind, as no other comparative retrospective chart review on the performance of VASCU-GUARD vascular patches from the old and new packaging has been published yet. The project will contribute to the scientific knowledge about long-term outcomes associated with the use of patch material during endarterectomies.
Primary Outcome
Retrospective review of ultrasound recordings and ultrasound reports at one-month, 3-months, 6-months and 1-year follow-up after endarterectomy - if available, to evaluate patch patency, morphology, integrity, complications, and blood flow dynamics
Interventions
- PROCEDURE Carotid endarterectomy (CEA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-02-01 |
What the finished NCT07048067 record still lists
NCT07048067 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Carotid endarterectomy (CEA) is the first listed.
NCT07048067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07048067 about?
NCT07048067 is a clinical study titled "Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment". VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior t...
What is the current status of trial NCT07048067?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2023-01-01. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT07048067?
The interventions under investigation include: Carotid endarterectomy (CEA) (PROCEDURE).
Who is sponsoring clinical trial NCT07048067?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI